GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human BRCA1 brct in complex with nonphosphopeptide inhibitor

Analyse Crystal structure of human BRCA1 brct in complex with nonphosphopeptide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4OFB
Type
protein
Length
221 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Breast cancer type 1 susceptibility protein; Nonphosphopeptide inhibitor
UniProt
P38398
Ligands
ACE, NH2
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABreast cancer type 1 susceptibility proteinprotein20935% helix, 19% strandP38398
BNonphosphopeptide inhibitorprotein120% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B
  • NH2 · Amino group · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11040.430.7818empty
2620.350.7816empty

Interfaces

1 interface between chains.

  • A–B · 736 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (nonstandard, covalent ligand).

Compared structures

  • 4OFB · Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P38398 · AlphaFold monomer V2.0 prediction for breast cancer type 1 susceptibility protein (P38398) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.